SUSQUEHANNA INTERNATIONAL GROUP, LLP - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 51 filers reported holding GLYCOMIMETICS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$378,300
+15.3%
252,200
+33.7%
0.00%
Q2 2023$328,110
+44.4%
188,569
+4.6%
0.00%
Q1 2023$227,189
-52.9%
180,309
+13.2%
0.00%
Q4 2022$482,715
+905.7%
159,312
+101.6%
0.00%
Q2 2022$48,000
-69.6%
79,018
-43.1%
0.00%
Q1 2022$158,000
-90.0%
138,840
-87.3%
0.00%
Q4 2021$1,580,000
+90.1%
1,097,016
+189.3%
0.00%
Q3 2021$831,000
-28.3%
379,151
-24.1%
0.00%
Q2 2021$1,159,000
+41.3%
499,799
+83.4%
0.00%
Q1 2021$820,000
-35.9%
272,460
-19.9%
0.00%
Q4 2020$1,280,000
+204.0%
340,314
+148.6%
0.00%
Q3 2020$421,000
+5.2%
136,868
+28.5%
0.00%
Q2 2020$400,000
+700.0%
106,508
+387.1%
0.00%
Q1 2020$50,000
-27.5%
21,865
+67.1%
0.00%
Q4 2019$69,000
-69.2%
13,083
-74.9%
0.00%
Q3 2019$224,000
-94.4%
52,046
-84.6%
0.00%
Q2 2019$4,030,000
+518.1%
337,927
+545.4%
0.00%
Q1 2019$652,000
-3.7%
52,361
+11.4%
0.00%
Q3 2018$677,000
-60.4%
47,000
-55.7%
0.00%
Q2 2018$1,710,000
-72.2%
106,000
-72.0%
0.00%
-100.0%
Q1 2018$6,145,000
+5.5%
378,600
+9.1%
0.00%0.0%
Q4 2017$5,826,000
+219.4%
346,952
+166.2%
0.00%
+100.0%
Q3 2017$1,824,000
-15.4%
130,329
-32.5%
0.00%
Q2 2017$2,155,000193,0510.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,544,262$10,880,0000.44%
NEA Management Company, LLC 9,089,041$10,361,0000.30%
Intellectus Partners, LLC 90,500$103,0000.03%
PRENTISS SMITH & CO INC 14,000$16,0000.01%
Eversept Partners, LP 100,579$114,6600.01%
ACADIAN ASSET MANAGEMENT LLC 1,990,087$2,267,0000.01%
PURA VIDA INVESTMENTS, LLC 87,678$100,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 155,400$177,0000.00%
Coastal Bridge Advisors, LLC 10,000$11,0000.00%
ALGERT GLOBAL LLC 28,004$32,0000.00%
View complete list of GLYCOMIMETICS INC shareholders